blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3725327

EP3725327 - PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  31.10.2025
Database last updated on 14.03.2026
FormerRequest for examination was made
Status updated on  18.09.2020
Most recent event   Tooltip31.10.2025Withdrawal of applicationpublished on 03.12.2025  [2025/49]
Applicant(s)For all designated states
Immatics Biotechnologies GmbH
Paul-Ehrlich-Strasse 15
72076 Tübingen / DE
[2020/43]
Inventor(s)01 / DI MARCO, Moreno
Memmingerstrasse 18/1
72072 Tübingen / DE
02 / HAEN, Sebastian
Brombergstrasse 15
72070 Tübingen / DE
03 / KOWALEWSKI, Daniel
Peter-Imhoff-Straße 1
72138 Kirchentellinsfurt / DE
04 / LÖFFLER, Markus
Sandgrabenstrasse 20
72119 Ammerbuch / DE
05 / NELDE, Annika
Hagellochter Weg 17
42070 Tuebingen / DE
06 / RAMMENSEE, Hans-Georg
Sommerhalde 3
72070 Unterjesingen / DE
07 / STEVANOVIC, Stefan
Auf der Burg 3
72074 Tübingen / DE
08 / TRAUTWEIN, Nico
Pelargusstrasse 2
70180 Stuttgart / DE
09 / WALZ, Juliane Sarah
Gartenstrasse 71
72076 Tübingen / DE
 [2020/43]
Representative(s)Michalski Hüttermann & Partner Patentanwälte mbB
Kaistraße 16A
40221 Düsseldorf / DE
[N/P]
Former [2020/43]Michalski Hüttermann & Partner Patentanwälte mbB
Speditionstraße 21
40221 Düsseldorf / DE
Application number, filing date20175071.810.04.2018
[2020/43]
Priority number, dateDE20171010769710.04.2017         Original published format: DE102017107697
US201762483702P10.04.2017         Original published format: US 201762483702 P
[2020/43]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP3725327
Date:21.10.2020
Language:EN
[2020/43]
Type: A3 Search report 
No.:EP3725327
Date:20.01.2021
Language:EN
[2021/03]
Search report(s)(Supplementary) European search report - dispatched on:EP23.12.2020
ClassificationIPC:A61K39/00, C07K14/47, G01N33/50, A61P35/00
[2020/43]
CPC:
A61K39/0011 (EP,CN,US); C07K14/70539 (EP,KR,US); C07K14/4748 (EP,CN,US);
C07K14/7051 (CN,KR,US); A61K35/17 (EP,CN,US); A61K38/08 (US);
A61K39/001111 (EP,CN,US); A61K40/11 (EP,CN,US); A61K40/42 (EP,CN,US);
A61P35/00 (EP,CN,KR,US); A61P35/02 (CN); C07K16/2818 (US);
C07K16/2833 (KR,US); C07K16/30 (CN); C07K7/06 (US);
C12N15/115 (US); C12N15/85 (KR); C12N5/0636 (EP,CN,KR,US);
G01N33/505 (US); G01N33/5758 (KR); A61K2039/55527 (KR);
A61K2039/55533 (KR); A61K38/00 (KR); C07K2319/70 (US);
C12N2310/16 (US); C12N2501/998 (CN) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/43]
Extension statesBA15.05.2020
ME15.05.2020
Validation statesKH15.05.2020
MA15.05.2020
MD15.05.2020
TN15.05.2020
TitleGerman:PEPTIDE UND KOMBINATION DAVON ZUR VERWENDUNG IN DER IMMUNTHERAPIE GEGEN KREBS[2020/43]
English:PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS[2020/43]
French:PEPTIDES ET COMBINAISONS DE PEPTIDES DESTINÉS À ÊTRE UTILISÉS EN IMMUNOTHÉRAPIE ANTICANCÉREUSE[2020/43]
Examination procedure15.05.2020Examination requested  [2020/43]
20.07.2021Amendment by applicant (claims and/or description)
29.10.2025Application withdrawn by applicant  [2025/49]
Parent application(s)   TooltipEP18722906.7  / EP3609530
Fees paidRenewal fee
15.05.2020Renewal fee patent year 03
27.05.2021Renewal fee patent year 04
16.03.2022Renewal fee patent year 05
30.03.2023Renewal fee patent year 06
27.03.2024Renewal fee patent year 07
08.04.2025Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
30.04.202104   M06   Fee paid on   08.06.2021
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y] WO2016146751  (IMMATICS BIOTECHNOLOGIES GMBH et al.)
 [Y] WO2009075883  (UNIV GEORGIA RES FOUND et al.)
 [Y] WO2016170139  (IMMATICS BIOTECHNOLOGIES GMBH et al.)
 [A] WO2011113819  (IMMATICS BIOTECHNOLOGIES GMBH et al.)
by applicantWO2007028574
 EP1760088
 US4897445
 US2013096016
 WO9518145
 US4440859
 US4530901
 US4582800
 US4677063
 US4678751
 US4704362
 US4710463
 US4757006
 US4766075
 US4810648
 US5849589
 US6406705
 EP2112253
 WO2014071978
 WO2014191359
 WO03068201
 WO2004084798
 WO0172768
 WO03070752
 US4816567
 WO9429348
 US4342566
 US2010113300
 US2013115191
 WO2004033685
 WO2004074322
 WO2012056407
 WO2013057586
 WO9726328
   AVIGAN, D. ET AL., CLIN CANCER RES., vol. 10, 2004, pages 4699 - 4708
   ALLISON, J. P. ET AL., SCIENCE, vol. 270, 1995, pages 932 - 933
   AMPIE, L. ET AL., FRONT ONCOL., vol. 5, 2015, pages 12
   ANDERSEN, R. S. ET AL., NAT.PROTOC., vol. 7, 2012, pages 891 - 902
   APPAY, V. ET AL., EUR.J IMMUNOL., vol. 36, 2006, pages 1805 - 1814
   BANCHEREAU, J. ET AL., CELL, vol. 106, 2001, pages 271 - 274
   BEATTY, G. ET AL., J IMMUNOL, vol. 166, 2001, pages 2276 - 2282
   BEGGS, J. D., NATURE, vol. 275, 1978, pages 104 - 109
   BERMAN, R. S. ET AL., NATIONAL CANCER INSTITUTE: PDQ(R) COLON CANCER TREATMENT, 2015
   BERMAN, R. S. ET AL., NATIONAL CANCER INSTITUTE: PDQ(R) RECTAL CANCER TREATMENT, 2015
   BOULTER, J. M. ET AL., PROTEIN ENG, vol. 16, 2003, pages 707 - 711
   BRAUMULLER, H. ET AL., NATURE, 2013
   BRAY, F. ET AL., INT J CANCER, vol. 132, 2013, pages 1133 - 1145
   BROSSART, P. ET AL., BLOOD, vol. 90, 1997, pages 1594 - 1599
   BRUCKDORFER, T. ET AL., CURR.PHARM.BIOTECHNOL., vol. 5, 2004, pages 29 - 43
   BUTTERFIELD, L. H. ET AL., CLIN CANCER RES, vol. 12, 2006, pages 4163 - 4170
   BUTTERFIELD, L. H. ET AL., CLIN CANCER RES, vol. 9, 2003, pages 5902 - 5908
   CARD, K. F. ET AL., CANCER IMMUNOL IMMUNOTHER., vol. 53, 2004, pages 345 - 357
   CHANG, Y. S. ET AL., CANCER CHEMOTHER.PHARMACOL., vol. 59, 2007, pages 561 - 574
   CHAPIRO, J. ET AL., RADIOL.MED., vol. 119, 2014, pages 476 - 482
   COHEN, C. J. ET AL., J MOL RECOGNIT., vol. 16, 2003, pages 324 - 332
   DENKBERG, G. ET AL., J IMMUNOL, vol. 171, 2003, pages 4974 - 4978
   COHEN, S. N. ET AL., PROC.NATI.ACAD.SCI.U.S.A, vol. 69, 1972, pages 2110 - 2114
   COLIGAN, J. E. ET AL., CURRENT PROTOCOLS IN PROTEIN SCIENCE, 1995
   COLOMBETTI, S. ET AL., J IMMUNOL., vol. 176, 2006, pages 2730 - 2738
   ENGUITA-GERMAN, M. ET AL., WORLD J HEPATOL., vol. 6, 2014, pages 716 - 737
   FALK, K. ET AL., NATURE, vol. 351, 1991, pages 290 - 296
   FERLAY ET AL., GLOBOCAN 2012 V1.0, CANCER INCIDENCE AND MORTALITY WORLDWIDE: IARC
   CANCERBASE, 2013, Retrieved from the Internet
   FERRE, H. ET AL., PROTEIN SCI., vol. 12, 2003, pages 551 - 559
   FOLLENZI, A. ET AL., NAT GENET., vol. 25, 2000, pages 217 - 222
   FONG, L. ET AL., PROC.NATI.ACAD.SCI.U.S.A, vol. 98, 2001, pages 8809 - 8814
   GABRILOVICH, D. I. ET AL., NAT MED., vol. 2, 1996, pages 1096 - 1103
   GATTINONI, L. ET AL., NAT REV.LMMUNOL, vol. 6, 2006, pages 383 - 393
   GNJATIC, S. ET AL., PROC NATI.ACAD.SCI.U.S.A, vol. 100, 2003, pages 8862 - 8867
   GODKIN, A. ET AL., INT.LMMUNOL, vol. 9, 1997, pages 905 - 911
   GRAGERT, L. ET AL., HUM.LMMUNOL., vol. 74, 2013, pages 1313 - 1320
   GREEN, M. R. ET AL., MOLECULAR CLONING, A LABORATORY MANUAL, 2012
   GREENFIELD, E. A., ANTIBODIES: A LABORATORY MANUAL, 2014
   GUSTAFSSON, C. ET AL., TRENDS BIOTECHNOL., vol. 22, 2004, pages 346 - 353
   HARNDAHL, M. ET AL., EUR.J IMMUNOL., vol. 42, 2012, pages 1405 - 1416
   HOLTL, L. ET AL., CLIN.CANCER RES., vol. 8, 2002, pages 3369 - 3376
   HORIG, H. ET AL., CANCER IMMUNOL IMMUNOTHER., vol. 49, 2000, pages 504 - 514
   HWANG, M. L. ET AL., J IMMUNOL., vol. 179, 2007, pages 5829 - 5838
   JUNG, G. ET AL., PROC NATL ACAD SCI U S A, vol. 84, 1987, pages 4611 - 4615
   KAUFMAN, H. L. ET AL., CLIN CANCER RES, vol. 14, 2008, pages 4843 - 4849
   KIBBE, A. H., HANDBOOK OF PHARMACEUTICAL EXCIPIENTS RD, 2000
   KOIDO, S. ET AL., WORLD J GASTROENTEROL., vol. 19, 2013, pages 8531 - 8542
   KRIEG, A. M., NAT REV.DRUG DISCOV., vol. 5, 2006, pages 471 - 484
   KUBALL, J. ET AL., BLOOD, vol. 109, 2007, pages 2331 - 2338
   LEE, W. C. ET AL., J IMMUNOTHER., vol. 28, 2005, pages 496 - 504
   LEITLINIE MAGENKARZINOM, 2012
   LEITLINIEN FUR DIAGNOSTIK UND THERAPIE IN DER NEUROLOGIE, 2014
   WALTER, S. ET AL., NAT MED., vol. 18, 2012, pages 1254 - 1261
   LJUNGGREN, H. G. ET AL., J EXP.MED., vol. 162, 1985, pages 1745 - 1759
   LLOVET, J. M. ET AL., N.ENGI.J MED., vol. 359, 2008, pages 378 - 390
   LONGENECKER, B. M. ET AL., ANN N.Y.ACAD.SCI., vol. 690, 1993, pages 276 - 291
   LUKAS, T. J. ET AL., PROC.NATI.ACAD.SCI.U.S.A, vol. 78, 1981, pages 2791 - 2795
   LUNDBLAD, R. L., CHEMICAL REAGENTS FOR PROTEIN MODIFICATION, 2004
   MARTEN, A. ET AL., CANCER IMMUNOL.IMMUNOTHER., vol. 51, 2002, pages 637 - 644
   MASSARI, F. ET AL., CANCER TREAT.REV., vol. 41, 2015, pages 114 - 121
   MATSUEDA, S. ET AL., WORLD J GASTROENTEROL., vol. 20, 2014, pages 1657 - 1666
   MEZIERE, C. ET AL., J IMMUNOL, vol. 159, 1997, pages 3230 - 3237
   MIYAGI, Y. ET AL., CLIN CANCER RES, vol. 7, 2001, pages 3950 - 3962
   MORGAN, R. A. ET AL., SCIENCE, vol. 314, 2006, pages 126 - 129
   MORTARA, L. ET AL., CLIN CANCER RES., vol. 12, 2006, pages 3435 - 3443
   MOULTON, H. M. ET AL., CLIN CANCER RES, vol. 8, 2002, pages 2044 - 2051
   MUMBERG, D. ET AL., PROC.NATI.ACAD.SCI.U.S.A, vol. 96, 1999, pages 8633 - 8638
   OKUNO, K. ET AL., EXP.THER MED., vol. 2, 2011, pages 73 - 79
   OSTERGAARD, PEDERSEN L. ET AL., EUR.J IMMUNOL., vol. 31, 2001, pages 2986 - 2996
   PALMER, D. H. ET AL., HEPATOLOGY, vol. 49, 2009, pages 124 - 132
   PLEBANSKI, M. ET AL., EUR.J IMMUNOL, vol. 25, 1995, pages 1783 - 1787
   PORTA, C. ET AL., VIROLOGY, vol. 202, 1994, pages 949 - 955
   SEEGER, F. H. ET AL., IMMUNOGENETICS, vol. 49, 1999, pages 571 - 576
   REINISCH, W. ET AL., J IMMUNOTHER., vol. 25, 2002, pages 489 - 499
   RINI, B. I. ET AL., CURR.OPIN.ONCOL., vol. 20, 2008, pages 300 - 306
   RINI, B. I. ET AL., CANCER, vol. 107, 2006, pages 67 - 74
   ROCK, K. L. ET AL., SCIENCE, vol. 249, 1990, pages 918 - 921
   RODENKO, B. ET AL., NAT PROTOC., vol. 1, 2006, pages 1120 - 1132
   SAIKI, R. K. ET AL., SCIENCE, vol. 239, 1988, pages 487 - 491
   SANGRO, B. ET AL., J CLIN ONCOL, vol. 22, 2004, pages 1389 - 1397
   SCHMITT, T. M. ET AL., HUM.GENE THER., vol. 20, 2009, pages 1240 - 1248
   SCHOLTEN, K. B. ET AL., CLIN IMMUNOL., vol. 119, 2006, pages 135 - 145
   SHERMAN, F. ET AL., LABORATORY COURSE MANUAL FOR METHODS IN YEAST GENETICS, 1986
   SHI, M. ET AL., WORLD J GASTROENTEROL., vol. 10, 2004, pages 1146 - 1151
   SINGH-JASUJA, H. ET AL., CANCER IMMUNOL.IMMUNOTHER., vol. 53, 2004, pages 187 - 195
   SMALL, E. J. ET AL., J CLIN ONCOL., vol. 24, 2006, pages 3089 - 3094
   STINTZING, S., F1000PRIME.REP., vol. 6, 2014, pages 108
   SU, Z. ET AL., CANCER RES., vol. 63, 2003, pages 2127 - 2133
   TAKAYAMA, T. ET AL., CANCER, vol. 68, 1991, pages 2391 - 2396
   TAKAYAMA, T. ET AL., LANCET, vol. 356, 2000, pages 802 - 807
   TEUFEL, R. ET AL., CELL MOL LIFE SCI., vol. 62, 2005, pages 1755 - 1762
   THAKKAR, J. P. ET AL., CANCER EPIDEMIOL.BIOMARKERS PREV., vol. 23, 2014, pages 1985 - 1996
   TRAN, E. ET AL., SCIENCE, vol. 344, 2014, pages 641 - 645
   WILHELM, S. M. ET AL., CANCER RES, vol. 64, 2004, pages 7099 - 7109
   WILLCOX, B. E. ET AL., PROTEIN SCI., vol. 8, 1999, pages 2418 - 2423
   WILSON, P. M. ET AL., NAT REV.CLIN ONCOL, vol. 11, 2014, pages 282 - 298
   WTTIG, B. ET AL., HUM.GENE THER., vol. 12, 2001, pages 267 - 278
   ZAREMBA, S. ET AL., CANCER RES., vol. 57, 1997, pages 4570 - 4577
   ZUFFEREY, R. ET AL., J VIROL., vol. 73, 1999, pages 2886 - 2892
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.